- Home
- HNRG vs ABSI Comparison
HNRG vs ABSI Comparison
Compare HNRG & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HNRG
- ABSI
- Stock Information
- Founded
- HNRG 1949
- ABSI 2011
- Country
- HNRG United States
- ABSI United States
- Employees
- HNRG N/A
- ABSI N/A
- Industry
- HNRG Coal Mining
- ABSI Biotechnology: Pharmaceutical Preparations
- Sector
- HNRG Energy
- ABSI Health Care
- Exchange
- HNRG Nasdaq
- ABSI Nasdaq
- Market Cap
- HNRG 413.8M
- ABSI 353.8M
- IPO Year
- HNRG N/A
- ABSI 2021
- Fundamental
- Price
- HNRG $15.31
- ABSI $2.75
- Analyst Decision
- HNRG Strong Buy
- ABSI Strong Buy
- Analyst Count
- HNRG 2
- ABSI 5
- Target Price
- HNRG $16.00
- ABSI $8.40
- AVG Volume (30 Days)
- HNRG 700.7K
- ABSI 2.5M
- Earning Date
- HNRG 05-12-2025
- ABSI 05-13-2025
- Dividend Yield
- HNRG N/A
- ABSI N/A
- EPS Growth
- HNRG N/A
- ABSI N/A
- EPS
- HNRG N/A
- ABSI N/A
- Revenue
- HNRG $404,394,000.00
- ABSI $4,534,000.00
- Revenue This Year
- HNRG N/A
- ABSI $158.58
- Revenue Next Year
- HNRG $24.45
- ABSI $93.12
- P/E Ratio
- HNRG N/A
- ABSI N/A
- Revenue Growth
- HNRG N/A
- ABSI N/A
- 52 Week Low
- HNRG $4.86
- ABSI $2.01
- 52 Week High
- HNRG $15.22
- ABSI $6.33
- Technical
- Relative Strength Index (RSI)
- HNRG 64.72
- ABSI 42.92
- Support Level
- HNRG $14.11
- ABSI $2.85
- Resistance Level
- HNRG $15.65
- ABSI $2.94
- Average True Range (ATR)
- HNRG 0.62
- ABSI 0.19
- MACD
- HNRG -0.01
- ABSI -0.03
- Stochastic Oscillator
- HNRG 83.41
- ABSI 14.13
About HNRG Hallador Energy Company
Hallador Energy Co is a coal mining company with operations in Indiana, USA, and it is part of the electric power generation industry. The operations of the company are divided into two primary reportable segments, the Coal Operations and Electric Operations segments. The majority of revenue is earned from the Coal Operations segment.
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.